The document addresses the conditions and requirements for the clearance of pharmaceutical products, raw materials, and medicinal plants, issued by the Saudi Food and Drug Authority, with the aim of protecting public health. The updates include the cancellation of the requirement for a commitment not to act on commercial shipments, the necessity to print the registration number on the packages, and the amendment of the acceptance rate for the validity of products from 70% to 50%. Suppliers must ...